Chronic lymphocytic leukaemia: diagnosis and management An overview of how to diagnose, manage and monitor patients with chronic lymphocytic leukaemia, emphasising the important role of pharmacists.… Supported content
Engineering precision: developing the next generation of antibody drug conjugates Researchers are working to create a new generation of these targeted cancer therapies to improve efficacy and minimise off-target adverse effects.…
Testicular cancer: symptoms, diagnosis and management An overview of testicular cancer, its affected populations, diagnostic procedures and treatment options.…
NICE recommends olaparib for advanced breast cancer in final draft guidance The drug has previously been recommended for some types of ovarian cancer in England and for prostate cancer in Scotland.…
BRUKINSA is now reimbursed across the UK for R/R MZL Read more to learn how BRUKINSA could benefit your patients with R/R MZL.… Promotional content
Health inequalities included in updated cancer referral guidelines The Scottish government's ‘Cancer Strategy for Scotland 2023–2033’ highlights that there is “convincing evidence” that socioeconomic and health disparities are linked with increased diagnoses of more advanced cancers.…
NICE overturns decision on blood cancer treatment elranatamab Elranatamab is now recommended as a fourth-line treatment for relapsed and refractory multiple myeloma, according to updated guidance from the National Institute for Health and Care Excellence.…
NICE lifts restrictions on myeloma treatment teclistamab in final draft guidance The updated guidance recommends the monoclonal antibody for anyone with relapsed or refractory multiple myeloma who has received three or more lines of treatment and whose myeloma has progressed.…
CAR-T infusions delivered to ‘more than 80’ patients in Wales, says NHS Wales The NHS Wales Joint Commissioning Committee has enabled 100 patients in Wales to receive an advanced therapy medicinal product to date.…
Pharmacy teams identify patients with ‘red-flag’ cancer symptoms in early diagnosis project Exclusive: Of those identified, 17 people presenting with red-flag symptoms received a formal consultation with a pharmacist during the six-month project.…
